Poor healthcare is one of the greatest causes of poverty. For an individual earning less than $2 a day, this presents significant challenges from taking time off work to taking out loans for medical care in places like India where over 70% of the population lives without insurance. The average up-front cost to monitoring is roughly 4000 rps, or $80, with additional 1000 rps ($20) cost for every 50 strip bottle purchased.
Patients are unable to purchase blood glucose strips individually, unlike many products in India, which results in higher upfront costs and increases the barriers to purchasing products designed to improve the overall management of those living with chronic diseases. Average diabetic monitoring by US standards is 5-7 times per diem, or roughly $1.75. We lower these costs significantly and hope to improve the dismal rates of blood glucose testing within India which has less than 6% of the population testing more than once per quarter.
Pictured: One of our first screenings where we diagnosed over 30% of the population having diabetes. Worldwide diabetes is at roughly 8% prevalence.